↓ Skip to main content

Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development

Overview of attention for book
Cover of 'Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Rationale for the Effective Use of Pharmacokinetics and Pharmacodynamics in Early Drug Development
  3. Altmetric Badge
    Chapter 2 The Case for Preclinical Pharmacodynamics
  4. Altmetric Badge
    Chapter 3 Utility of Kinetic, Dynamic, and Metabolic Data in Nonclinical Pharmacology/Toxicology Studies
  5. Altmetric Badge
    Chapter 4 Pharmacokinetics and Drug Metabolism in Animal Studies (ADME, Protein Binding, Mass Balance, Animal Models)
  6. Altmetric Badge
    Chapter 5 Nonclinical Considerations: Disposition of Drugs
  7. Altmetric Badge
    Chapter 6 Use of Acute Toxicity Data in the Design and Interpretation of Subchronic and Chronic Toxicity Studies
  8. Altmetric Badge
    Chapter 7 Use of Pharmacokinetics and Pharmacodynamics in Preclinical Studies to Guide Dosage Escalation Schemes in Phase I Studies of Anticancer Drugs
  9. Altmetric Badge
    Chapter 8 Use of Toxicokinetic Principles in Drug Development: Bridging Preclinical and Clinical Studies
  10. Altmetric Badge
    Chapter 9 Preclinical Pharmacodynamics of Central Nervous System Active Agents
  11. Altmetric Badge
    Chapter 10 Preclinical Pharmacodynamics of Antihypertensives
  12. Altmetric Badge
    Chapter 11 Preclinical Pharmacodynamics of Anxiolytics: Effects of Chronic Benzodiazepine Administration
  13. Altmetric Badge
    Chapter 12 Guidelines for Development of a New Diuretic Agent
  14. Altmetric Badge
    Chapter 13 Preclinical Pharmacodynamics of Anti-Inflammatory Drugs
  15. Altmetric Badge
    Chapter 14 The Role of Pharmacokinetics in the Drug Development Process
  16. Altmetric Badge
    Chapter 15 Implementation of an Effective Pharmacokinetics Research Program in Industry
  17. Altmetric Badge
    Chapter 16 Pharmacoepidemiology, Population Pharmacokinetics and New Drug Development
  18. Altmetric Badge
    Chapter 17 Assessment of Pharmacokinetic Drug Interactions in Clinical Drug Development
  19. Altmetric Badge
    Chapter 18 Pharmacokinetic/Pharmacodynamic Models and Methods
  20. Altmetric Badge
    Chapter 19 Pharmacokinetic and Pharmacodynamic Modeling Applied to Anesthetic Drugs
  21. Altmetric Badge
    Chapter 20 Pharmacodynamic/Pharmacokinetic Relationships for Rapidly Acting Drugs (NSAIDS) in Rheumatoid Arthritis: Problems and Preliminary Solutions
  22. Altmetric Badge
    Chapter 21 The Value of Plasma-Warfarin Measurement
  23. Altmetric Badge
    Chapter 22 Clinical Pharmacodynamics of Cardiovascular Agents: Focus on Sudden Cardiac Death
  24. Altmetric Badge
    Chapter 23 The Benzodiazepines: Kinetic-Dynamic Relationships
  25. Altmetric Badge
    Chapter 24 The Integration of Pharmacodynamics and Pharmacokinetics in Rational Drug Development
  26. Altmetric Badge
    Chapter 25 Concentration-Controlled Trials: Basic Concepts, Design, and Implementation
  27. Altmetric Badge
    Chapter 26 Opportunities for Integration of Pharmacokinetics, Pharmacodynamics and Toxicokinetics in Rational Drug Development
Attention for Chapter 25: Concentration-Controlled Trials: Basic Concepts, Design, and Implementation
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
32 Dimensions
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Concentration-Controlled Trials: Basic Concepts, Design, and Implementation
Chapter number 25
Book title
Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development
Published by
Springer US, February 1993
DOI 10.1007/978-1-4757-1520-0_25
Book ISBNs
978-1-4757-1522-4, 978-1-4757-1520-0
Authors

Lilly P. Sanathanan, Carl C. Peck

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.